Carl Zeiss Meditec (CZMWY) Stock Price, News & Analysis

Company Overview

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery. In the Ophthalmic Devices segment, Carl Zeiss Meditec develops and markets diagnostic instruments such as optical coherence tomography (OCT) systems, fundus cameras and tonometers, as well as therapeutic laser platforms for refractive surgery and cataract treatment. Within Microsurgery, the firm produces high-precision surgical microscopes and handheld visualization tools that serve specialties including neurosurgery, ear-nose-throat (ENT) and dentistry. Each product line is designed to deliver enhanced image quality, ergonomic operation and reliable performance in clinical environments.

Operating across Europe, the Americas, Asia-Pacific and select emerging markets, Carl Zeiss Meditec maintains a broad international sales and service network. The company collaborates closely with hospitals, clinics and research institutions to support clinical training and product development. Its global footprint is supported by regional offices, production sites and service centers, ensuring timely access to technical support and spare parts.

Governed by a management board of experienced executives in optics, medical technology and healthcare, Carl Zeiss Meditec continues to emphasize research and development. The company reinvests a significant portion of its revenues into new technologies, with the aim of advancing patient outcomes and increasing surgical precision. Through ongoing innovation and strong aftermarket support, Carl Zeiss Meditec remains a key partner for healthcare professionals worldwide.

Key Stats

• Today's Range: $52.74 to $53.84
• 50-Day Range: $48.04 to $55.39
• 52-Week Range: $46.13 to $76.28
• Volume: 1,063 shs
• Average Volume: 3,999 shs
• Market Capitalization: N/A
• P/E Ratio: 57.84
• Dividend Yield: 0.56%
• Price Target: N/A
• Consensus Rating: Hold

CZMWY Stock Analysis - Frequently Asked Questions

How have CZMWY shares performed this year?

Carl Zeiss Meditec's stock was trading at $47.50 at the start of the year. Since then, CZMWY stock has increased by 12.0% and is now trading at $53.2150.

How do I buy shares of Carl Zeiss Meditec?

Shares of CZMWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/26/2025
• Next Earnings (Estimated): 12/11/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CZMWY
• CIK: N/A
• Web: www.zeiss.com
• Phone: 493641220115
• Fax: N/A
• Employees: 4,823
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 57.84
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A